This occurs primarily through the formation of DNA adducts resulting in mutations in a number of vital genes implicated in tumorigenesis, including KRAS, which is mutated in nearly all pancreatic cancers [12,13,14]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.